Prenatal Flutamide Enhances Survival in a Myogenic Mouse Model of Spinal Bulbar Muscular Atrophy
Open Access
- 4 August 2010
- journal article
- modeling neurodegenerative-diseases-in-vivo
- Published by S. Karger AG in Neurodegenerative Diseases
- Vol. 8 (1-2), 25-34
- https://doi.org/10.1159/000313682
Abstract
Background: Spinal bulbar muscular atrophy (SBMA) is caused by a CAG repeat expansion mutation in the androgen receptor (AR) gene, and mutant AR is presumed to act in motoneurons to cause SBMA. However, we found that mice overexpressing wild-type (wt) AR solely in skeletal muscle fibers display the same androgen-dependent disease phenotype as when mutant AR is broadly expressed, challenging the assumptions that only an expanded AR can induce disease and that SBMA is strictly neurogenic. We have previously reported that AR toxicity was ligand dependent in our model, and that very few transgenic (tg) males survived beyond birth. Methods: We tested whether the AR antagonist flutamide could block perinatal toxicity. tg males were treated prenatally with flutamide and assessed for survival and motor behavior in adulthood. Results: Prenatal treatment with flutamide rescued tg male pups from perinatal death, and, as adults, such perinatally rescued tg males showed an SBMA phenotype that was comparable to that of previously described untreated tg males. Moreover, tg males carrying a mutant endogenous allele for AR – the testicular feminization mutation (tfm) – and thus having functional AR only in muscle fibers nevertheless displayed the same androgen-dependent disease phenotype as adults. Conclusions: These mice represent an excellent model to study the myogenic contribution to SBMA as they display many of the core features of disease as other mouse models. These data demonstrate that AR acting exclusively in muscle fibers is sufficient to induce SBMA symptoms and that flutamide is protective perinatally.Keywords
This publication has 40 references indexed in Scilit:
- Cytoplasmic retention of polyglutamine-expanded androgen receptor ameliorates disease via autophagy in a mouse model of spinal and bulbar muscular atrophyHuman Molecular Genetics, 2009
- Spinal and bulbar muscular atrophy: a motoneuron or muscle disease?Current Opinion in Pharmacology, 2008
- The role of androgen receptors in the masculinization of brain and behavior: What we've learned from the testicular feminization mutationHormones and Behavior, 2008
- Overexpression of wild-type androgen receptor in muscle recapitulates polyglutamine diseaseProceedings of the National Academy of Sciences of the United States of America, 2007
- Abnormalities of Germ Cell Maturation and Sertoli Cell Cytoskeleton in Androgen Receptor 113 CAG Knock-In Mice Reveal Toxic Effects of the Mutant ProteinThe American Journal of Pathology, 2006
- The AXH Domain of Ataxin-1 Mediates Neurodegeneration through Its Interaction with Gfi-1/Senseless ProteinsCell, 2005
- α-Synuclein Locus Triplication Causes Parkinson's DiseaseScience, 2003
- Ligand Promotes Intranuclear Inclusions in a Novel Cell Model of Spinal and Bulbar Muscular AtrophyOnline Journal of Public Health Informatics, 2002
- Stability of an expanded trinucleotide repeat in the androgen receptor gene in transgenic miceNature Genetics, 1995
- Testosterone levels in plasma and testes of neonatal miceJournal of Steroid Biochemistry, 1988